This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp. with financial support from Tonix. The two organizations ...
Tonix Pharmaceuticals Announces Efficacy and Safety of Single-Dose TNX-801 Vaccine Against Monkeypox
Tonix Pharmaceuticals announced that its vaccine candidate TNX-801, a live attenuated horsepox virus vaccine, has shown efficacy in protecting animals against lethal monkeypox challenges after a ...
Clade I, the culprit in the current 2025 version of global epidemic mpox, is highly transmissible and is spreading within families and among children, whereas the 2022 Clade II mpox - still spreading ...
On August 14, 2024, the WHO determined that the upsurge of mpox in a growing number of countries in Africa constitutes a public health emergency of international concern 1-4: cases of the potentially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results